Glossaries Addiction Expand Secondary Navigation Menu Recovery Expand Secondary Navigation Menu 12 Step talk Alzheimer's Autism Disability ECT Forensic HIPAA Memory OCD Pharmacology Expand Secondary Navigation Menu Psychopharmacology Psychopathology Psychotherapy Expand Secondary Navigation Menu ABA Adlerian Cognitive Behavior Therapy EMDR Family Gestalt IFS Jungian MI Narrative NLP PCT Psychoanalytic Psychodynamic TA Unified Psychotherapy RDoC Reimbursement Sleep Medicine Expand Secondary Navigation Menu Chronobiology EEG Polysomnography Stuttering TMS Treatment VNS Connect with us Become a fan on Facebook Follow us on X Subscribe (sample) to our Newsletter Follow us on Pinterest Comtan entacapone Company Novartis FDA Label Indications 10/19/1999 adjunct to levodopa/carbidopa to treat patients with idiopathic Parkinson’s Disease who experience the signs and symptoms of end-of-dose “wearing-off” (so-called “fluctuating” patients) Companies Novartis Molecular entities entacapone Daily Posts CNS Drug: #CNSDODNotable Person: #BHCPODPhobia: #BNphobiaTerm: #BHCTOD National Conference #Hashtags 11/12-14 AMERSA#AMERSA202611/12-15 AAAP#AAAP202611/12-15 ABCT#ABCTNOW11/14-18 SfN#SfN2611/18-21 ACLP#ACLP2026
